AzTrials
AzTrials

Anterior Labial Wall DefectEarly Phase 1NCT05162885

Effect of Sodium Alendronate on the Final Implant Stability.

A Early Phase 1 study testing Socket Preservation technique in people with Anterior Labial Wall Defect, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

evaluation of the final implant stability after its placement in sockets preserved with two different socket preservation materials Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Anterior Labial Wall Defect
What is being tested?
Socket Preservation technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
1 May 2021to 1 Oct 2022
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients with seeking implant drive prosthesis after socket has been preserved by either technique.
  • Patients with seeking implant drive prosthesis with Salama Class 3 defective sockets.
  • Both genders males and females will be included.

Who cannot join

  • General contraindications to implant surgery.
  • Patient seeking immediate implant placement.
  • Subjected to irradiation in the head and neck area less than 1 year before implantation.
  • Untreated periodontitis.
  • Poor oral hygiene and motivation.
  • Uncontrolled diabetes.
Show all 16Show fewer
  • Pregnant or nursing.
  • Substance abuse.
  • Psychiatric problems or unrealistic expectations.
  • Severe bruxism or clenching.
  • Immunosuppressed or immunocompromised.
  • Treated or under treatment with intravenous amino-bisphosphonates.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Unable to open mouth sufficiently to accommodate the surgical tooling.
  • Patients participating in other studies, if the present protocol could not be properly
  • followed. Referred only for implant placement or unable to attend a 5-year follow-up

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Hossam Abdallah Mohammed Ghazally

    Cairo, Manial, 11553

    Nadia Galal Galal, PHD, 01002177637 ext. 0020, Nadia.Galal@dentistry.cu.edu.eg

    Nadia Galal Galal, PHD

    Recruiting

Other trials in Egypt

About this study

Official title: Effect of Sodium Alendronate Versus Sticky Bone as Socket Preservation Materials on the Final Implant Stability. A Randomized Clinical Trial

evaluation of the final implant stability after its placement in sockets preserved with two different socket preservation materials

Read the detailed description

compare the stability of implant placement using Osstell ISQ "resonance frequency analyzer", and marginal bone resorption and bone density around implant by X-ray analysis in different socket preservation techniques comparing sodium alendronate with the sticky bone graft technique

Being tested
Socket Preservation technique
Keywords
Stability, Sodium Alendronate, Implant, Sticky bone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Socket Preservation techniqueProcedure or surgery

    Also called Implant in socket preserved with sodium alenderonate drug

    Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama\&salama Class 3 labial wall defect

Study groups in NCT05162885
Study groupRoleWhat they receive
implant placement in defective Sockets preserved with alendronic acid spongeActive comparatoranesthesia according the site of implant placement were administered using mepivacaine HCl (2%) with levonordefrin 1:20 000 (Scandonest 2%; Septodont, Saint- Maur-des-Fossés, France). Injection to control pain and bleeding for hemostasis. Crestal incision with a full thickness mucoperiosteal flap was reflected .A pilot drill will be used to start the osteotomy preparation, then different drilling sizes will be used to attain the final drill size and the planed implant height and width according to Cone Beam CT. Implants were screwed directly into the osteotomy site, primarily the screwing was done mechanically by Fixture Mount Connection attached to the implant carrier. The created gap sutured passively to allow tension-free interrupted closure using 3-0 coated undyed braided polyglactin 910 suture material.
Receives: Procedure: Socket Preservation technique
Implant placement in Defective sockets preserved with sticky boneActive comparatoranesthesia according the site of implant placement were administered using mepivacaine HCl (2%) with levonordefrin 1:20 000 (Scandonest 2%; Septodont, Saint- Maur-des-Fossés, France). Injection to control pain and bleeding for hemostasis. Crestal incision with a full thickness mucoperiosteal flap was reflected .A pilot drill will be used to start the osteotomy preparation, then different drilling sizes will be used to attain the final drill size and the planed implant height and width according to Cone Beam CT. Implants were screwed directly into the osteotomy site, primarily the screwing was done mechanically by Fixture Mount Connection attached to the implant carrier. The created gap sutured passively to allow tension-free interrupted closure using 3-0 coated undyed braided polyglactin 910 suture material.
Receives: Procedure: Socket Preservation technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implant stability

    Calculate the final implant stability of two groups using Osstell "resonance frequency analyzer"

    Measured: 3-4 months after Dental implant placement

Secondary outcomes (1)
  1. marginal bone

    Evaluation of marginal bone resorption around implant in two groups using superimposition x-ray (CBCT) software analysis

    Measured: 3-4 months after Dental implant placement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2021
  2. Study start1 May 2021
  3. Primary completion23 May 2021
  4. Study completion1 Oct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05162885
Sponsor's protocol ID
omfs335
Status last verified
Dec 2021
First submitted
7 Dec 2021
Last updated
17 Dec 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Socket Preservation technique in people with Anterior Labial Wall Defect, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implant stability (time frame: 3-4 months after Dental implant placement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in